Jushi Holdings (JUSHF) Current Leases (2021 - 2026)
Jushi Holdings (JUSHF) posted quarterly Current Leases of $10.9 million for Q2 2026, up 9.1% year-over-year from $10.0 million in Q2 2025, and little changed quarter-over-quarter from $10.9 million in Q1 2026.
Jushi Holdings (JUSHF) Current Leases (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has reported Current Leases for 6 consecutive years, with $10.9 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Current Leases rose 9.1% year-over-year to $10.9 million; the TTM figure through Jun 2026 stood at $10.9 million (up 9.1% YoY), while the FY2025 annual figure was $11.1 million, up 15.97% from the prior year.
- Current Leases steadied at $10.9 million in Q2 2026 per JUSHF's latest filing, from $10.9 million in the prior quarter.
- Across five years, Current Leases topped out at $13.1 million in Q2 2022 and bottomed at $8.7 million in Q3 2023.
- Historically, Current Leases has averaged $10.2 million across 5 years, with a median of $10.0 million in 2025.
- Annual changes were most pronounced in 2023 — Current Leases slumped 33.02% — and 2025, when it increased 15.97%.
- Jushi Holdings' Current Leases stood at $11.4 million in 2022, then decreased by 21.79% to $8.9 million in 2023, then advanced by 7.97% to $9.6 million in 2024, then climbed by 15.97% to $11.1 million in 2025, then decreased by 1.65% to $10.9 million in 2026.
- Business Quant data shows JUSHF's Current Leases at $10.9 million in Q2 2026, $10.9 million in Q1 2026, and $11.1 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Jushi Holdings | 83.87 Mn | 50.54 Mn | 31.53 Mn | 10.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.94 Mn |
| Mar 31, 2026 | 10.89 Mn |
| Dec 31, 2025 | 11.13 Mn |
| Sep 30, 2025 | 10.29 Mn |
| Jun 30, 2025 | 10.03 Mn |
| Mar 31, 2025 | 9.75 Mn |
| Dec 31, 2024 | 9.59 Mn |
| Sep 30, 2024 | 9.31 Mn |
| Jun 30, 2024 | 8.96 Mn |
| Mar 31, 2024 | 9.12 Mn |
| Dec 31, 2023 | 8.89 Mn |
| Sep 30, 2023 | 8.74 Mn |
| Jun 30, 2023 | 8.79 Mn |
| Mar 31, 2023 | 10.29 Mn |
| Dec 31, 2022 | 11.36 Mn |
| Sep 30, 2022 | 12.74 Mn |
| Jun 30, 2022 | 13.12 Mn |
| Dec 31, 2021 | 12.62 Mn |